Minnesota Oncology is pleased to introduce our newest Edina Clinic physician, Patrick Dreyer, DO.

“My core belief is that an oncologist must treat the whole patient and in the process include their family. I very much enjoyed teaching medical residents when I was a chief medical resident, and likewise when I was chief oncology fellow. I use a similar approach to treating patients and family, as only with an adequate understanding of all the aspects of a cancer can a patient and family make a decision that they consider reasonable.”

Dr. Dreyer joins Minnesota Oncology after completing his fellowship and residency at Larking Community Hospital.

Dr. Dreyer is board-certified in Internal Medicine and fellowship trained in oncology and hematology.  His areas of special interest include breast cancer, neuroendocrine tumors, non-small cell lung cancer and gastrointestinal malignancy.

“Today there are so many treatment options and so much more we can offer patients than even 5 years ago. As an oncologist it is my duty to stay up to date with the current literature, so I can offer my patients the best care available.” 

Learn more about Dr. Dreyer and request an appointment here.

Share

Categories

Tags

Recent Posts

#
March 21, 2024

We know the importance of safeguarding your data and are committed to maintaining the highest standards of privacy and security. Change Healthcare reports that their privacy office and information security teams are working to understand the impact to patients. At this time, we have not received any notices that your personal or medical data has been compromised because of this outage.

#
March 20, 2024

March is Myeloma Awareness Month. Myeloma begins when a plasma cell becomes abnormal. The abnormal cell divides to make copies of itself. The new cells divide again and again, making more and more abnormal cells. These abnormal plasma cells are called myeloma cells.

#
March 19, 2024

Approximately 81,600 new cases of kidney cancer ― more than 52,000 in men and 29,000 in women ― will be diagnosed in the U.S. this year, and 14,390 people ― 9,450 men and 4,940 women ― will die from the disease, according to the American Cancer Society.